BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27028396)

  • 1. Atypical Fibroxanthoma.
    López L; Vélez R
    Arch Pathol Lab Med; 2016 Apr; 140(4):376-9. PubMed ID: 27028396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleomorphic Dermal Sarcoma.
    Saleh JS; Whittington CP; Bresler SC; Patel RM
    Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: A cautionary (and molecularly annotated) tale.
    Lefferts JA; Loehrer AP; Yan S; Green DC; Deharvengt SJ; LeBlanc RE
    J Cutan Pathol; 2020 Jun; 47(6):541-547. PubMed ID: 31943331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bone fide atypical fibroxanthoma of penis.
    Cuomo R; Addesso M; Altieri R; D'Antonio A
    Urol Ann; 2014 Oct; 6(4):381-3. PubMed ID: 25371625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence.
    Pham JP; Staeger R; Frew JW
    J Am Acad Dermatol; 2024 May; 90(5):e171-e173. PubMed ID: 38185252
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence".
    Ørholt M; Eriksson F; Herly M; Vester-Glowinski P
    J Am Acad Dermatol; 2024 May; 90(5):e175-e176. PubMed ID: 38185254
    [No Abstract]   [Full Text] [Related]  

  • 7. A Case of Pleomorphic Dermal Sarcoma: Giant Exophytic Tumor of the Medial Canthus.
    Moody R; Darji K; Missall TA; Chow P; Behshad R
    Dermatopathology (Basel); 2023 Dec; 11(1):13-18. PubMed ID: 38247725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical fibroxanthoma of the cheek-case report with dermatoscopy and dermatopathology.
    Inskip M; Magee J; Weedon D; Rosendahl C
    Dermatol Pract Concept; 2014 Apr; 4(2):77-80. PubMed ID: 24855581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High intratumoural 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Gambichler T; Razeghpour F; Sorescu E; Stücker M; Rached NA; Becker JC; Susok L
    Br J Dermatol; 2024 Apr; ():. PubMed ID: 38666307
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic atypical fibroxanthoma: the importance of structured reporting for cutaneous sarcoma-like tumour.
    Yap M; Harvey NT; Mesbah Ardakani N; Wood BA
    Pathology; 2024 May; ():. PubMed ID: 38834438
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical Fibroxanthoma Revisited.
    Mentzel T; Requena L; Brenn T
    Surg Pathol Clin; 2017 Jun; 10(2):319-335. PubMed ID: 28477883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
    Soleymani T; Tyler Hollmig S
    Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
    Soleymani T; Aasi SZ; Novoa R; Hollmig ST
    Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case for diagnosis. Atypical fibroxanthoma.
    Sarac E; Yuksel M; Turkmen IC; Ozdemir M
    An Bras Dermatol; 2019; 94(2):239-241. PubMed ID: 31090836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical fibroxanthoma: Systematic review and meta-analysis of treatment with Mohs micrographic surgery or excision.
    Tolkachjov SN; Kelley BF; Alahdab F; Erwin PJ; Brewer JD
    J Am Acad Dermatol; 2018 Nov; 79(5):929-934.e6. PubMed ID: 29981390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical fibroxanthoma management: Recurrence, metastasis and disease-specific death.
    Polcz MM; Sebaratnam DF; Fernández-Peñas P
    Australas J Dermatol; 2018 Feb; 59(1):10-25. PubMed ID: 28815551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Fibroxanthoma.
    Chapman LW; Yu SS; Arron ST
    Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.